Odyssey Health Net Loss Balloons to $4.1M in H1 FY2026 on Shareholder Deficit

Odyssey Health, Inc., a Nevada-based healthcare company, posted a net loss of $4.09 million for the six months ending January 31, 2026, compared to a loss of $1.24 million in the same period of fiscal 2025. The loss per share reached $0.04, up from $0.01 a year earlier. Read more earnings reports.

The deficit deepened despite the company narrowing its operating loss to $485,132 from $736,020 year-over-year. The widening bottom-line loss reflects significant non-operating charges not detailed in the operating figures.

For the three months ending January 31, 2026 alone, Odyssey Health recorded a net loss of $3.60 million, a sharp acceleration from the $220,126 loss in the same quarter of fiscal 2025. The three-month operating loss for the period was $181,942, compared to $156,593 in the prior-year quarter.

Cash consumed by operations totaled $568,257 for the six-month period, nearly double the $295,192 outflow in the first half of fiscal 2025. The company raised $1.17 million from financing activities, up from $300,000 in the prior period, helping boost cash and restricted cash to $616,327 as of January 31, 2026 from $7,187 a year earlier.

The company's balance sheet shows shareholder equity remained deeply negative at minus $10.60 million as of January 31, 2026, deteriorating from minus $6.95 million six months prior. Retained deficit widened to minus $66.83 million from minus $62.75 million at the end of July 2025.

Total assets climbed to $721,304 as of January 31, 2026, a sharp increase from $49,723 at the end of fiscal 2025, driven entirely by current assets. Current liabilities rose to $11.32 million from $7.00 million over the same period, with accounts payable holding steady near $1.62 million.

The company's common shares outstanding increased to 99.85 million as of January 31, 2026 from 96.71 million six months earlier. Weighted average shares used in earnings calculations totaled 106.95 million for the six-month period.